Clinical Laserthermia Systems AB (publ)
Stockholm Stock Exchange CLS-B.ST
Clinical Laserthermia Systems AB (publ) Free Cash Flow Yield on January 14, 2025: -126.66%
Clinical Laserthermia Systems AB (publ) Free Cash Flow Yield is -126.66% on January 14, 2025, a -488.50% change year over year. Free cash flow yield compares the return from free cash flow to the market cap; higher yield suggests attractive investment.
-
Clinical Laserthermia Systems AB (publ) 52-week high Free Cash Flow Yield is -0.21% on April 19, 2024, which is 99.83% above the current Free Cash Flow Yield.
-
Clinical Laserthermia Systems AB (publ) 52-week low Free Cash Flow Yield is -141.20% on August 06, 2024, which is -11.48% below the current Free Cash Flow Yield.
-
Clinical Laserthermia Systems AB (publ) average Free Cash Flow Yield for the last 52 weeks is -77.68%.
Key data
| Date | Free Cash Flow Yield | Market Value Added (MVA) | Price to Book Ratio (P/B) | Price to Earnings Ratio (P/E) |
|---|
Market news
Loading...
Stockholm Stock Exchange: CLS-B.ST
| CEO | Mr. Dan Johansson Mogren |
| IPO Date | April 16, 2009 |
| Location | Sweden |
| Headquarters | Building 405 |
| Employees | 17 |
| Sector | Health Care |
| Industries | |
Description
Clinical Laserthermia Systems AB (publ) develops treatment tools for diseased tissue under the TRANBERG brand in Sweden. The company offers TRANBERG, a thermal therapy system designed to deliver laser energy to heat the target tissue. It also provides mobile laser unit, a controlling component with a wavelength of 1064 nanometers provides multiple options to control treatment. In addition, the company offers various gauge laser applicators, as well as provides temperature and treatment monitoring devices. Clinical Laserthermia Systems AB (publ) was incorporated in 2006 and is headquartered in Lund, Sweden.
Key trends
Past 5 years
Similar companies
Cantargia AB (publ)
USD 0.15
0.09%
StockViz Staff
January 15, 2025
Any question? Send us an email